RU96119966A - QUINOLA DERIVATIVE FOR THE TREATMENT OF URINE HOLDING - Google Patents
QUINOLA DERIVATIVE FOR THE TREATMENT OF URINE HOLDINGInfo
- Publication number
- RU96119966A RU96119966A RU96119966/04A RU96119966A RU96119966A RU 96119966 A RU96119966 A RU 96119966A RU 96119966/04 A RU96119966/04 A RU 96119966/04A RU 96119966 A RU96119966 A RU 96119966A RU 96119966 A RU96119966 A RU 96119966A
- Authority
- RU
- Russia
- Prior art keywords
- acid
- formula
- compound
- cyanophenyl
- trifluoromethyl
- Prior art date
Links
- 210000002700 Urine Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 9
- 238000006114 decarboxylation reaction Methods 0.000 claims 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N P-Toluenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- 241000658540 Ora Species 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- -1 (S) - ( -) - Trifluoromethyl-4- (3-cyanophenyl) -5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylic acid Chemical compound 0.000 claims 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims 2
- RUVMMEREJMHLOS-LBPRGKRZSA-N 3-[(4S)-5-oxo-2-(trifluoromethyl)-4,6,7,8-tetrahydro-1H-quinolin-4-yl]benzonitrile Chemical compound C1([C@@H]2C=C(NC3=C2C(CCC3)=O)C(F)(F)F)=CC=CC(C#N)=C1 RUVMMEREJMHLOS-LBPRGKRZSA-N 0.000 claims 2
- 229910004664 ORa Inorganic materials 0.000 claims 2
- 239000003377 acid catalyst Substances 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 238000004821 distillation Methods 0.000 claims 2
- OCJKUQIPRNZDTK-UHFFFAOYSA-N ethyl 4,4,4-trifluoro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)C(F)(F)F OCJKUQIPRNZDTK-UHFFFAOYSA-N 0.000 claims 2
- 150000002373 hemiacetals Chemical class 0.000 claims 2
- 239000012442 inert solvent Substances 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 2
- SECXISVLQFMRJM-UHFFFAOYSA-N n-methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims 1
- JPPWCQVADVNMGS-UHFFFAOYSA-N 2-cyanoethyl 4,4,4-trifluoro-3-oxobutanoate Chemical compound FC(F)(F)C(=O)CC(=O)OCCC#N JPPWCQVADVNMGS-UHFFFAOYSA-N 0.000 claims 1
- HGZJJKZPPMFIBU-UHFFFAOYSA-N 3-formylbenzonitrile Chemical compound O=CC1=CC=CC(C#N)=C1 HGZJJKZPPMFIBU-UHFFFAOYSA-N 0.000 claims 1
- WSGYTJNNHPZFKR-UHFFFAOYSA-N 3-hydroxypropanenitrile Chemical compound OCCC#N WSGYTJNNHPZFKR-UHFFFAOYSA-N 0.000 claims 1
- YGDGIAUJXPSGEC-UHFFFAOYSA-N 4-(3-cyanophenyl)-5-oxo-2-(trifluoromethyl)-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylic acid Chemical compound OC(=O)C1=C(C(F)(F)F)NC(CCCC2=O)=C2C1C1=CC=CC(C#N)=C1 YGDGIAUJXPSGEC-UHFFFAOYSA-N 0.000 claims 1
- 229960000583 Acetic Acid Drugs 0.000 claims 1
- 239000005695 Ammonium acetate Substances 0.000 claims 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N Ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims 1
- VQUOGGCMULBZTG-ZDUSSCGKSA-N FC(F)(F)N1C=C[C@H](C=2C(CCCC12)=O)C1=CC(=CC=C1)C#N Chemical compound FC(F)(F)N1C=C[C@H](C=2C(CCCC12)=O)C1=CC(=CC=C1)C#N VQUOGGCMULBZTG-ZDUSSCGKSA-N 0.000 claims 1
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating Effects 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 230000001476 alcoholic Effects 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims 1
- 229940043376 ammonium acetate Drugs 0.000 claims 1
- 235000019257 ammonium acetate Nutrition 0.000 claims 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 229930006709 borneol Natural products 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical compound O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 claims 1
- 238000006297 dehydration reaction Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 1
- 239000012362 glacial acetic acid Substances 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
Claims (22)
где ORa обозначает спиртовой остаток, с ацетатом аммония, 3-цианобензальдегидом и 1,3-циклогександионом с получением соединения формулы IVа:
и (2) альтернативно: дегидрируют соединение формулы IVа до соединения формулы IV
и омыляют полученное соединение формулы IV с образованием кислоты формулы II:
или подвергают соединение формулы IVа катализируемой кислотой дегидратации и гидролизу, что дает кислоту формулы II; (3) выделяют соединение формулы II в виде соли S-(-)-α-метилбензиламина путем перекристаллизации из растворителя, и (4) декарбоксилируют выделенное соединение формулы П.15. The method of obtaining (S) - (-) - 2-trifluoromethyl-4- (3-cyanophenyl) -4,6,7,8-tetrahydro-5 (1H) quinolone, characterized in that the following steps are carried out: (1 a) interaction of acetoacetic ester of the formula III or its hemiacetal:
where ORa denotes an alcohol residue, with ammonium acetate, 3-cyanobenzaldehyde and 1,3-cyclohexanedione to obtain the compounds of formula IVa:
and (2) alternatively: a compound of formula IVa is dehydrated to a compound of formula IV
and the resulting compound of formula IV is saponified to form an acid of formula II:
or subject to a compound of formula IVa acid catalyzed dehydration and hydrolysis, which gives the acid of formula II; (3) isolate the compound of formula II as a salt of S - (-) - α-methylbenzylamine by recrystallization from a solvent, and (4) decarboxylate the isolated compound of formula P.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9407432A GB9407432D0 (en) | 1994-04-14 | 1994-04-14 | Heterocyclic derivative |
GB9407432.5 | 1994-04-14 | ||
PCT/GB1995/000845 WO1995028388A1 (en) | 1994-04-14 | 1995-04-13 | Quinolone derivative for treatment of urinary incontinence |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96119966A true RU96119966A (en) | 1998-12-27 |
RU2149870C1 RU2149870C1 (en) | 2000-05-27 |
Family
ID=10753541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96119966/04A RU2149870C1 (en) | 1994-04-14 | 1995-04-13 | Quinolone derivative for treatment of patient with enuresis and methods of its synthesis |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0755382B1 (en) |
JP (1) | JP3782445B2 (en) |
KR (1) | KR100344885B1 (en) |
CN (1) | CN1058708C (en) |
AT (1) | ATE202089T1 (en) |
AU (1) | AU700773B2 (en) |
BR (1) | BR9507366A (en) |
CA (1) | CA2187525C (en) |
CZ (1) | CZ284652B6 (en) |
DE (1) | DE69521310T2 (en) |
DK (1) | DK0755382T3 (en) |
ES (1) | ES2159633T3 (en) |
FI (2) | FI114705B (en) |
GB (1) | GB9407432D0 (en) |
GR (1) | GR3036482T3 (en) |
HK (1) | HK1013999A1 (en) |
HU (1) | HU215387B (en) |
MX (1) | MX9603920A (en) |
NO (1) | NO307177B1 (en) |
NZ (1) | NZ283779A (en) |
PL (2) | PL183095B1 (en) |
PT (1) | PT755382E (en) |
RU (1) | RU2149870C1 (en) |
SK (1) | SK281124B6 (en) |
WO (1) | WO1995028388A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE373642T1 (en) * | 1999-08-03 | 2007-10-15 | Abbott Lab | POTASSIUM CHANNEL ACTIVATORS |
US7074931B2 (en) | 2000-08-02 | 2006-07-11 | Astrazeneca Ab | Process for asymmetric synthesis of substituted 1,4 -dihydropyridines |
SE0200205D0 (en) * | 2002-01-24 | 2002-01-24 | Astrazeneca Ab | Method |
CN102532015B (en) * | 2012-01-18 | 2013-10-23 | 云南大学 | Solid-phase synthesis method of coumarin and analogue thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2003148A1 (en) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Coronary active 1,4-dihydropyridines |
GB9220570D0 (en) * | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
-
1994
- 1994-04-14 GB GB9407432A patent/GB9407432D0/en active Pending
-
1995
- 1995-04-13 HU HU9602747A patent/HU215387B/en not_active IP Right Cessation
- 1995-04-13 EP EP95915256A patent/EP0755382B1/en not_active Expired - Lifetime
- 1995-04-13 PL PL95343448A patent/PL183095B1/en not_active IP Right Cessation
- 1995-04-13 DK DK95915256T patent/DK0755382T3/en active
- 1995-04-13 CN CN95192577A patent/CN1058708C/en not_active Expired - Fee Related
- 1995-04-13 BR BR9507366A patent/BR9507366A/en not_active IP Right Cessation
- 1995-04-13 RU RU96119966/04A patent/RU2149870C1/en active
- 1995-04-13 AU AU22199/95A patent/AU700773B2/en not_active Ceased
- 1995-04-13 JP JP52680695A patent/JP3782445B2/en not_active Expired - Fee Related
- 1995-04-13 PL PL95316790A patent/PL182031B1/en not_active IP Right Cessation
- 1995-04-13 CZ CZ962981A patent/CZ284652B6/en not_active IP Right Cessation
- 1995-04-13 KR KR1019960705672A patent/KR100344885B1/en not_active IP Right Cessation
- 1995-04-13 NZ NZ283779A patent/NZ283779A/en not_active IP Right Cessation
- 1995-04-13 MX MX9603920A patent/MX9603920A/en not_active IP Right Cessation
- 1995-04-13 PT PT95915256T patent/PT755382E/en unknown
- 1995-04-13 SK SK1317-96A patent/SK281124B6/en not_active IP Right Cessation
- 1995-04-13 CA CA002187525A patent/CA2187525C/en not_active Expired - Fee Related
- 1995-04-13 WO PCT/GB1995/000845 patent/WO1995028388A1/en active IP Right Grant
- 1995-04-13 AT AT95915256T patent/ATE202089T1/en not_active IP Right Cessation
- 1995-04-13 ES ES95915256T patent/ES2159633T3/en not_active Expired - Lifetime
- 1995-04-13 DE DE69521310T patent/DE69521310T2/en not_active Expired - Fee Related
-
1996
- 1996-10-07 FI FI964019A patent/FI114705B/en active
- 1996-10-11 NO NO964345A patent/NO307177B1/en not_active IP Right Cessation
-
1998
- 1998-12-24 HK HK98115420A patent/HK1013999A1/en not_active IP Right Cessation
-
2001
- 2001-08-31 GR GR20010401341T patent/GR3036482T3/en not_active IP Right Cessation
-
2004
- 2004-03-04 FI FI20040352A patent/FI115630B/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4669040B2 (en) | Process for producing 4-oxoquinoline compound | |
JPS6051189A (en) | Thiazolidine derivative and its preparation | |
JP2002526534A (en) | Tetrahydroquinoline derivative having selective activity on retinoid X receptor | |
RU96119966A (en) | QUINOLA DERIVATIVE FOR THE TREATMENT OF URINE HOLDING | |
EP1302467A2 (en) | Process for the preparation of substituted thiazoline derivatives and their intermediate | |
EA026569B1 (en) | Processes for preparing certain pyrimidine compounds and intermediates thereof | |
CA2271396C (en) | Process for the preparation of shikimic acid and its derivatives | |
KR20010053337A (en) | Salts of Paroxetine | |
HU198200B (en) | Process for production of derivatives of quinoline carbonic acid | |
JP3338101B2 (en) | Process for producing aryl acrylic acids and their esters | |
SU1402261A3 (en) | Method of producing 5,6-dihydro-4h-cyclopent (b) thiophene-6-carboxylic acids | |
JP2991381B2 (en) | Novel quinolinecarboxylic acid derivatives, esters and salts thereof | |
HU203716B (en) | Process for producing optically active amino-acids | |
JP3838682B2 (en) | Process for producing 2-methyl-4-oxo-2-cyclohexenecarboxylic acid ester and novel intermediate thereof | |
JPH09309879A (en) | Alpha and beta-unsaturated ketone derivative | |
DE3312283A1 (en) | METHOD FOR PRODUCING UNBALANCED 1,4-DIHYDROPYRIDINE CARBONIC ACID ESTERS | |
EP0124742A2 (en) | Process for the preparation of symmetric 1,4-dihydropyridine-carboxylic esters | |
KR102051523B1 (en) | Synthetic method of tetrahydroisoquinoline derivatives | |
EP0021926B1 (en) | Process for the preparation of optically active allethrolone | |
US3538144A (en) | Colchicinic intermediates | |
JP2873040B2 (en) | Derivatization reagent for high-performance liquid chromatography | |
US6590101B2 (en) | Process for the preparation of fluoroquinolonecarboxylic acids | |
BANERJEE et al. | INVESTIGATION ON THE BY-PRODUCT OBTAINED IN THE COPEKNOEVENAGEL CONDENSATION OF ETHYL α-ACETOGLUTARATE WITH ETHYL CYANOACETATE | |
CH633778A5 (en) | Method of preparation of 4-chloroquinoleines. | |
SU545250A3 (en) | Method for preparing substituted biphenylyl butyric acid or its esters or its salts |